These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8428795

  • 1. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo.
    Sobottka SB, Berger MR, Eibl H.
    Int J Cancer; 1993 Feb 01; 53(3):418-25. PubMed ID: 8428795
    [Abstract] [Full Text] [Related]

  • 2. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB, Berger MR.
    Cancer Chemother Pharmacol; 1992 Feb 01; 30(5):385-93. PubMed ID: 1505077
    [Abstract] [Full Text] [Related]

  • 3. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR, Betsch B, Gebelein M, Amtmann E, Heyl P, Scherf HR.
    J Cancer Res Clin Oncol; 1993 Feb 01; 119(9):541-8. PubMed ID: 8392075
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
    Jendrossek V, Hammersen K, Erdlenbruch B, Kugler W, Krügener R, Eibl H, Lakomek M.
    Cancer Chemother Pharmacol; 2002 Jul 01; 50(1):71-9. PubMed ID: 12111115
    [Abstract] [Full Text] [Related]

  • 5. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
    Yanapirut P, Berger MR, Reinhardt M, Schmähl D.
    Arzneimittelforschung; 1991 Jun 01; 41(6):652-5. PubMed ID: 1930356
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo antitumoral activity of alkylphosphonates.
    Ries UJ, Fleer EA, Breiser A, Unger C, Stekar J, Fenneberg K, Eibl H.
    Eur J Cancer; 1992 Jun 01; 29A(1):96-101. PubMed ID: 1445752
    [Abstract] [Full Text] [Related]

  • 7. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.
    Unger C, Damenz W, Fleer EA, Kim DJ, Breiser A, Hilgard P, Engel J, Nagel G, Eibl H.
    Acta Oncol; 1989 Jun 01; 28(2):213-7. PubMed ID: 2736110
    [Abstract] [Full Text] [Related]

  • 8. Hexadecylphosphocholine: a new and selective antitumor drug.
    Eibl H, Unger C.
    Cancer Treat Rev; 1990 Sep 01; 17(2-3):233-42. PubMed ID: 2272038
    [Abstract] [Full Text] [Related]

  • 9. Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.
    Karia P, Patel KV, Rathod SSP.
    J Ethnopharmacol; 2018 May 10; 217():54-62. PubMed ID: 29366766
    [Abstract] [Full Text] [Related]

  • 10. D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
    Hilgard P, Klenner T, Stekar J, Nössner G, Kutscher B, Engel J.
    Eur J Cancer; 1997 Mar 10; 33(3):442-6. PubMed ID: 9155530
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C, Berger MR, Schuler B, Scherf HR, Garzon FT, Zeller WJ, Unger C, Eibl HJ, Schmähl D.
    Lipids; 1987 Nov 10; 22(11):930-4. PubMed ID: 3444388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
    Petru E, Berger MR, Zeller WJ, Kaufmann M.
    Eur J Cancer Clin Oncol; 1988 Jun 10; 24(6):1027-32. PubMed ID: 3409940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alkylphosphocholines: Effects on human leukemic cell lines and normal bone marrow cells.
    Konstantinov SM, Topashka-Ancheva M, Benner A, Berger MR.
    Int J Cancer; 1998 Aug 31; 77(5):778-86. PubMed ID: 9688313
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells.
    Eibl KH, Banas B, Schoenfeld CL, May CA, Neubauer AS, Priglinger S, Kampik A, Welge-Lussen U.
    Invest Ophthalmol Vis Sci; 2003 Aug 31; 44(8):3556-61. PubMed ID: 12882807
    [Abstract] [Full Text] [Related]

  • 19. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jan 15; 57(2):267-71. PubMed ID: 9000566
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
    Berger MR, Yanapirut P, Reinhardt M, Klenner T, Scherf HR, Schmeiser HH, Eibl H.
    Prog Exp Tumor Res; 1992 Jan 15; 34():98-115. PubMed ID: 1438807
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.